Literature DB >> 35075587

Inflammatory bowel disease as a new risk factor for dementia.

Marco Zuin1,2, Roberto De Giorgio3,4, Eleonora Capatti3,4, Elisa Boschetti5, Giovanni Zuliani3,4.   

Abstract

The prognostic impact of inflammatory bowel disease (IBD), chronic inflammatory conditions consisting of ulcerative colitis (UC), and Crohn's disease (CD) on the risk of dementia has been poorly investigated. We evaluated the risk of dementia in IBD patients by a systematic review and meta-analysis of the available data. Three studies, enrolling 121.827 patients [14.839 IBD (12.1%) and 106.961 (87.7%) controls, respectively] were included in the analysis. Of these, 57.7% (n = 8.571) had UC, while 42.2% (n = 6268) had CD. The mean follow-up period was 21.3 years. A random effect model revealed an aHR of 1.52 (95% CI 1.04-2.020, p = 0.01; I2 = 91.1%) for dementia in IBD patients. Sensitivity analysis confirmed yielded results. Subjects having a CD showed an aHR for dementia of 1.48 (95% CI 1.07-2.03, p = 0.001, I2 = 68.9%), while the risk among those with a history of UC did not reach the statistical significance (aHR: 1.47, 95% CI 0.95-2.82, p = 0.81, I2 = 89.9%). IBD males had an increased risk of dementia compared to women. IBD patients and in particular those with CD have an increased risk of dementia in the long-term period.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Dementia; Epidemiology; IBD

Mesh:

Year:  2022        PMID: 35075587     DOI: 10.1007/s40520-022-02076-1

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  9 in total

1.  Association Between Inflammatory Bowel Disease and Dementia: A Retrospective Cohort Study.

Authors:  Rebecca Zingel; Jens Bohlken; Karel Kostev
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 2.  The Gut Microbiome as a Therapeutic Target for Cognitive Impairment.

Authors:  Yi Sun; Liliana C Baptista; Lisa M Roberts; Patricia Jumbo-Lucioni; Lori L McMahon; Thomas W Buford; Christy S Carter
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-06-18       Impact factor: 6.053

3.  Comorbidity before and after a diagnosis of inflammatory bowel disease.

Authors:  Charles N Bernstein; Zoann Nugent; Seth Shaffer; Harminder Singh; Ruth Ann Marrie
Journal:  Aliment Pharmacol Ther       Date:  2021-06-22       Impact factor: 8.171

4.  Inflammatory bowel disease is associated with higher dementia risk: a nationwide longitudinal study.

Authors:  Bing Zhang; Hohui E Wang; Ya-Mei Bai; Shih-Jen Tsai; Tung-Ping Su; Tzeng-Ji Chen; Yen-Po Wang; Mu-Hong Chen
Journal:  Gut       Date:  2020-06-23       Impact factor: 31.793

Review 5.  Comorbidity and dementia: a scoping review of the literature.

Authors:  Frances Bunn; Anne-Marie Burn; Claire Goodman; Greta Rait; Sam Norton; Louise Robinson; Johan Schoeman; Carol Brayne
Journal:  BMC Med       Date:  2014-10-31       Impact factor: 8.775

6.  Systemic Molecular Mediators of Inflammation Differentiate Between Crohn's Disease and Ulcerative Colitis, Implicating Threshold Levels of IL-10 and Relative Ratios of Pro-inflammatory Cytokines in Therapy.

Authors:  Miranda G Kiernan; J Calvin Coffey; Shaheel M Sahebally; Paul Tibbitts; Emma M Lyons; Eimear O'leary; Funke Owolabi; Colum P Dunne
Journal:  J Crohns Colitis       Date:  2020-01-01       Impact factor: 9.071

7.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

Review 8.  Social Aspects of Dementia Prevention from a Worldwide to National Perspective: A Review on the International Situation and the Example of Italy.

Authors:  Giovanna Ricci
Journal:  Behav Neurol       Date:  2019-09-08       Impact factor: 3.342

Review 9.  Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.

Authors:  Gill Livingston; Jonathan Huntley; Andrew Sommerlad; David Ames; Clive Ballard; Sube Banerjee; Carol Brayne; Alistair Burns; Jiska Cohen-Mansfield; Claudia Cooper; Sergi G Costafreda; Amit Dias; Nick Fox; Laura N Gitlin; Robert Howard; Helen C Kales; Mika Kivimäki; Eric B Larson; Adesola Ogunniyi; Vasiliki Orgeta; Karen Ritchie; Kenneth Rockwood; Elizabeth L Sampson; Quincy Samus; Lon S Schneider; Geir Selbæk; Linda Teri; Naaheed Mukadam
Journal:  Lancet       Date:  2020-07-30       Impact factor: 79.321

  9 in total
  1 in total

1.  Effects of ulcerative colitis and Crohn's disease on neurodegenerative diseases: A Mendelian randomization study.

Authors:  Hong Li; Zheng Wen
Journal:  Front Genet       Date:  2022-08-15       Impact factor: 4.772

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.